Radha Munagala, University of Louisville, United States
Ioannis S. Pappas, Professor of pharmacology University of Thessaly, Greece
Swaranjit Singh,
Senior Principal Scientist
Institute of Microbial Technology, India
Submit manuscript at www.itmedicalteam.pl/submissions/molecular-enzymology-drug-targets.html or send as an e-mail attachment to the Editorial Office at [email protected]
Molecular Enzymology and Drug Targets journal aims is to publish the work of designing and synthesis of enzymes and high unmet medical need are based on innovative drug targets. This is an international journal for rapid dissemination of significant data related to enzymes and their use in biotechnology and drug discovery.
The basic enthusiasm of the journal is publishing new data related to the molecular aspects of enzymes, cellular lipid metabolism, biocatalysis, enzyme mechanisms and cellular functions in broader aspects of biology. Molecular Enzymologys interest include in all aspects related to enzymes like discovery of enzymes, enzyme structure, enzyme mechanisms, cellular and metabolic functions of enzymes, exploitation of enzymes for biotechnological and pharmaceutical applications, Enzymology, drug discovery, biochemical aspects of enzymes, bioinformatics, computational analysis, molecular modelling studies, new methods in enzyme expression and purification, biocatalysis, biomolecular engineering, enzyme kinetics and inhibitors. In spite of the great work done in the field of enzymes but there is no specific journal interested in enzymology and in related areas of drug discovery. Therefore, the journal Molecular Enzymology and Drug Targets will be unique in its discipline as it can be the first interest to authors working in the field of enzymology and related subjects.
The journal is an interdisciplinary medium serving several branches of life sciences. This Journals publishes original articles, short communications, notes, and mini reviews. Full length reviews are only published after invitation from the editorial board. Preliminary studies are inappropriate for publishing in Journal of Molecular enzymology and Drug Targets, unless the authors report the significance of their findings, in that case, the manuscript can be accepted. Average first decision of submitted manuscript is expected to be 14 days.
Articles published in Molecular Enzymology and Drug Targets have been cited by esteemed scholars and scientists all around the world. Molecular Enzymology and Drug Targets has got h-index 4 , which means every article in Molecular Enzymology and Drug Targets has got 4 average citations.
Abdelaziz El-hoshoudy*
Jemal Abdu*,Molla Kahssay , Frewein Yilma , Etsay Woldu, Desalegn Mersesa
Aishwarya Anand*, Radhika. A. R
Mohammed Yimam,Teshome Sosengo*,Gedefew Asmare
Julian Menter